Kilitch Drugs (India) Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, January 1, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ended December 31, 2025. The trading window closure applies to all designated persons of the company and their immediate relatives, as per SEBI (Prohibition of Insider Trading) Regulations, 2015. The date for the Board of Directors' meeting to approve the unaudited financial results for the quarter ended December 31, 2025, will be intimated in due course.